Expanded Insights From a Case Study on Long-Acting Injectable Cabotegravir and Rilpivirine in Pregnancy

被引：0

作者：

Ziemba, Lauren ^{[1
]}

Ketchum, Rachel ^{[1
]}

Brummel, Sean ^{[1
]}

机构：

[1] Harvard T H Chan Sch Publ Hlth, Ctr Biostat AIDS Res, Boston, MA 02115 USA

来源：

CLINICAL INFECTIOUS DISEASES | 2025年 / 81卷 / 01期

关键词：

D O I：

10.1093/cid/ciae635

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：e9 / e10

页数：2

共 4 条

[1] Exploring predictors of HIV-1 virologic failure to long-acting cabotegravir and rilpivirine: a multivariable analysis [J].

Cutrell, Amy G. ;

Schapiro, Jonathan M. ;

Perno, Carlo F. ;

Kuritzkes, Daniel R. ;

Quercia, Romina ;

Patel, Parul ;

Polli, Joseph W. ;

Dorey, David ;

Wang, Yongwei ;

Wu, Sterling ;

Van Eygen, Veerle ;

Crauwels, Herta ;

Ford, Susan L. ;

Baker, Mark ;

Talarico, Christine L. ;

St Clair, Marty ;

Jeffrey, Jerry ;

White, C. Thomas ;

Vanveggel, Simon ;

Vandermeulen, Kati ;

Margolis, David A. ;

Aboud, Michael ;

Spreen, William R. ;

van Lunzen, Jan .

AIDS, 2021, 35 (09) :1333-1342

[2]

IMPAACT Network, IMPAACT 2040 PHASE 3

[3]

van der Wekken-Pas L, 2024, CLIN INFECT DIS, V79, P1468, DOI 10.1093/cid/ciae242

[4]

ViiV Healthcare, 2021, PRODUCT MONOGRAPH

← 1 →